newsNovo Nordisk industry membership reinstated18 March 2025 | By Catherine Eckford (European Pharmaceutical Review)The company now has ABPI membership after a two-year suspension involving concerns relating to its compliance with the industry body’s code of conduct.
newsTakeda plans 2026 CEO succession30 January 2025 | By Catherine Eckford (European Pharmaceutical Review)The biopharmaceutical company’s executive transition follows a multi-year succession process to support its next chapter.
newsUK biotech on “positive trajectory”, says BIA27 January 2025 | By Catherine Eckford (European Pharmaceutical Review)Cutting-edge science and large international investment are driving growth in the UK’s biotech sector, the organisation’s new report reveals.
newsAstraZeneca Canadian investment to drive R&D growth24 January 2025 | By Catherine Eckford (European Pharmaceutical Review)The US$570m investment will contribute to advancing AstraZeneca’s global clinical pipeline, a key goal of its strategy to 2030.
articlePotential blockbuster drugs to watch in 202510 January 2025 | By European Pharmaceutical ReviewEleven drugs are poised to make waves in the pharmaceutical industry in 2025, according to the annual report.
newsCHMP recommends novel long-acting HIV treatment17 December 2024 | By Catherine Eckford (European Pharmaceutical Review)The positive opinion means HIV patients could overcome challenges of taking daily oral regimens, says ViiV Healthcare's Chief Medical Officer.
newsInnovative biologic prefilled syringe approved in EU13 December 2024 | By Catherine Eckford (European Pharmaceutical Review)The new treatment option provides a convenient alternative to currently available vials of the bispecific antibody for EU patients with common vision conditions.
newsPharmapack Europe 2025: Eco barrier packaging to launch11 December 2024 | By European Pharmaceutical Review, LOG Pharma Primary PackagingThe innovative line of barrier bottles provides unmatched protection against moisture and oxygen and reduces production costs, LOG Pharma Primary Packaging says.
newsSanofi investment to enhance antibody bioproduction in France18 November 2024 | By Catherine Eckford (European Pharmaceutical Review)This bioproduction investment in Lyon, France supports Sanofi in its goals to lead in the immunology sector.
articleLife sciences response to 2024 Autumn Budget31 October 2024 | By Catherine Eckford (European Pharmaceutical Review)Research and innovation is highlighted in the UK’s Autumn Budget as a priority ‘crucial national asset’ to aid long-term economic growth.
newsEli Lilly appoints Chief AI Officer9 October 2024 | By Catherine Eckford (European Pharmaceutical Review)The new appointee will create AI and machine learning solutions to support Eli Lilly’s medicines for patients globally.
newsEuropean manufacturing facility to strengthen gene therapy supply3 October 2024 | By Catherine Eckford (European Pharmaceutical Review)The new manufacturing facility in Finland will aid global supply of the first FDA-approved intravesical non-replicating gene therapy for adults with a common cancer.
newsInnovative medicine production site inaugurated in France11 September 2024 | By Catherine Eckford (European Pharmaceutical Review)Sanofi’s novel manufacturing unit in France shortens production timelines and enables rapid changes in production capacities for medicines such as biologics and vaccines.
newsNovartis collaboration to innovate subcutaneous drug delivery28 August 2024 | By Catherine Eckford (European Pharmaceutical Review)The multi-target biologic-focused agreement could enhance treatment convenience by improving subcutaneous administration options for patients.
newsAbbVie appoints new Chief Scientific Officer11 July 2024 | By Catherine Eckford (European Pharmaceutical Review)Following the appointment, Thomas Hudson, AbbVie’s current Senior Vice President, Chief Scientific Officer, Global Research, will retire.
